LUV00996 The provision of services for formulation development, clinical batch manufacture and distribution of the active pharmaceutical ingredient (API), Resveratrol: the COLO-PREVENT study
University of Leicesterservices
What the buyer wrote
LUV00996 The provision of services for formulation development, clinical batch manufacture and distribution of the active pharmaceutical ingredient (API), Resveratrol: the COLO-PREVENT study
Bid for this and lost? There is a short window in which the decision can be questioned.
Awarded to
Details
- What the buyer calls it
- LUV00996 The provision of services for formulation development, clinical batch manufacture and distribution of the active pharmaceutical ingredient (API), Resveratrol: the COLO-PREVENT study
- How they are buying
- Advertised, open to anyoneAny supplier could bid without being invited first.
- Type
- services
Who the buyer named
Anthony Midgley was the named contact on this notice.